Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang BioAsia Pharmaceutical Co., Ltd. (BioAsia Pharmaceutical) is a biomedical high-tech enterprise specializing in the research, development, and production of medicinal products derived from entomogenous fungi, specifically cordycipitoid fungi. Established in 2011 and based in Pinghu, China, the company integrates advanced mycology research with industrial-scale solid-state fermentation to create drugs, health supplements, and functional food ingredients. BioAsia Pharmaceutical manages one of the world's leading fungal culture collections and operates R&D facilities in China and Sweden. Its product portfolio, marketed under brands such as "Cicada Flower" and "Plantamed," focuses on immune modulation and metabolic health. The company's scientific leadership includes internationally recognized experts in fungal pathology and biotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioAsia Pharmaceutical.